321 related articles for article (PubMed ID: 9839728)
1. Risk factors for contralateral breast cancer in Chennai (Madras), India.
Gajalakshmi CK; Shanta V; Hakama M
Int J Epidemiol; 1998 Oct; 27(5):743-50. PubMed ID: 9839728
[TBL] [Abstract][Full Text] [Related]
2. Survival from contralateral breast cancer.
Gajalakshmi CK; Shanta V; Hakama M
Breast Cancer Res Treat; 1999 Nov; 58(2):115-22. PubMed ID: 10674875
[TBL] [Abstract][Full Text] [Related]
3. Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.
Prater J; Valeri F; Korol D; Rohrmann S; Dehler S
J Cancer Res Clin Oncol; 2016 Feb; 142(2):365-71. PubMed ID: 26298838
[TBL] [Abstract][Full Text] [Related]
4. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
Gao X; Fisher SG; Emami B
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139
[TBL] [Abstract][Full Text] [Related]
5. Second primary in the contralateral breast after treatment of breast cancer.
Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor RK
Radiother Oncol; 2008 Feb; 86(2):171-6. PubMed ID: 17961777
[TBL] [Abstract][Full Text] [Related]
6. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
[TBL] [Abstract][Full Text] [Related]
7. Reproductive history and risk of second primary breast cancer: the WECARE study.
Largent JA; Capanu M; Bernstein L; Langholz B; Mellemkaer L; Malone KE; Begg CB; Haile RW; Lynch CF; Anton-Culver H; Wolitzer A; Bernstein JL
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):906-11. PubMed ID: 17507614
[TBL] [Abstract][Full Text] [Related]
8. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.
Reiner AS; John EM; Brooks JD; Lynch CF; Bernstein L; Mellemkjær L; Malone KE; Knight JA; Capanu M; Teraoka SN; Concannon P; Liang X; Figueiredo JC; Smith SA; Stovall M; Pike MC; Haile RW; Thomas DC; Begg CB; Bernstein JL
J Clin Oncol; 2013 Feb; 31(4):433-9. PubMed ID: 23269995
[TBL] [Abstract][Full Text] [Related]
9. Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting.
Gierach GL; Curtis RE; Pfeiffer RM; Mullooly M; Ntowe EA; Hoover RN; Nyante SJ; Feigelson HS; Glass AG; Berrington de Gonzalez A
JAMA Oncol; 2017 Feb; 3(2):186-193. PubMed ID: 27711920
[TBL] [Abstract][Full Text] [Related]
10. Contralateral breast cancer: a clinico-pathological study of second primaries in opposite breasts after treatment of breast malignancy.
Shankar A; Roy S; Malik A; Kamal VK; Bhandari R; Kishor K; Mahajan M; Sachdev J; Jeyaraj P; Rath G
Asian Pac J Cancer Prev; 2015; 16(3):1207-11. PubMed ID: 25735357
[TBL] [Abstract][Full Text] [Related]
11. The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy.
Abdalla I; Thisted RA; Heimann R
Cancer J; 2000; 6(4):266-72. PubMed ID: 11038147
[TBL] [Abstract][Full Text] [Related]
12. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.
Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL
Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983
[TBL] [Abstract][Full Text] [Related]
13. The genetic epidemiology of second primary breast cancer.
Bernstein JL; Thompson WD; Risch N; Holford TR
Am J Epidemiol; 1992 Oct; 136(8):937-48. PubMed ID: 1456270
[TBL] [Abstract][Full Text] [Related]
14. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
[TBL] [Abstract][Full Text] [Related]
15. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer.
Bernstein JL; Thompson WD; Risch N; Holford TR
Am J Epidemiol; 1992 Oct; 136(8):925-36. PubMed ID: 1456269
[TBL] [Abstract][Full Text] [Related]
16. Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992-2016.
Ramin C; Withrow DR; Davis Lynn BC; Gierach GL; Berrington de González A
Breast Cancer Res; 2021 Feb; 23(1):24. PubMed ID: 33596988
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.
Vichapat V; Garmo H; Holmberg L; Fentiman IS; Tutt A; Gillett C; Lüchtenborg M
Breast Cancer Res Treat; 2011 Nov; 130(2):609-18. PubMed ID: 21671018
[TBL] [Abstract][Full Text] [Related]
18. Inferior survival for young patients with contralateral compared to unilateral breast cancer: a nationwide population-based study in the Netherlands.
Font-Gonzalez A; Liu L; Voogd AC; Schmidt MK; Roukema JA; Coebergh JW; de Vries E; Soerjomataram I
Breast Cancer Res Treat; 2013 Jun; 139(3):811-9. PubMed ID: 23760860
[TBL] [Abstract][Full Text] [Related]
19. [Contralateral breast cancer: metastasis or second primary cancer?].
Broët P; de la Rochefordière A; Scholl SM; Fourquet A; Mosseri V; Durand JC; Pouillart P; Asselain B
Bull Cancer; 1996 Oct; 83(10):870-6. PubMed ID: 8952638
[TBL] [Abstract][Full Text] [Related]
20. Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study.
Vichapat V; Garmo H; Holmqvist M; Liljegren G; Wärnberg F; Lambe M; Fornander T; Adolfsson J; Lüchtenborg M; Holmberg L
J Clin Oncol; 2012 Oct; 30(28):3478-85. PubMed ID: 22927521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
